Ribavirin

"Ribavirin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.

Descriptor ID	D012254
MeSH Number(s)	D13.570.800.790
Concept/Terms	Ribavirin Ribavirin Ribovirin Tribavirin Rebetol Rebetol Virazole Virazole Vilona Ribasphere Ribasphere Viramide Viramide Virazide Virazide ICN-1229 ICN-1229 ICN 1229 ICN1229 Ribamide Ribamide Ribamidil Ribamidyl

Below are MeSH descriptors whose meaning is more general than "Ribavirin".

Chemicals and Drugs [D]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleosides [D13.570]
Ribonucleosides [D13.570.800]
Ribavirin [D13.570.800.790]

Below are MeSH descriptors whose meaning is related to "Ribavirin".

Below are MeSH descriptors whose meaning is more specific than "Ribavirin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ribavirin" by people in this website by year, and whether "Ribavirin" was a major or minor topic of these publications.

Bar chart showing 19 publications over 12 distinct years, with a maximum of 3 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	2	0	2
2007	2	0	2
2009	0	2	2
2010	1	0	1
2011	1	0	1
2012	2	0	2
2013	1	2	3
2014	1	1	2
2015	0	1	1
2016	1	0	1
2017	0	1	1
2018	0	1	1

Below are the most recent publications written about "Ribavirin" by people in Profiles.

Kouris G, Hydery T, Greenwood BC, Lavitas P, Price M, Clements K, Alper CJ, Lenz K, Jeffrey PL. Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population. J Manag Care Spec Pharm. 2018 Jul; 24(7):591-597.

View in: PubMed
Spooner LM, Abraham GM. Sustained virological response in a treatment-experienced patient with hepatitis C virus genotype 6 infection: Follow-up on a reported case. Am J Health Syst Pharm. 2017 04 15; 74(8):555.

View in: PubMed
Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431.

View in: PubMed
Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016 Feb; 63(2):408-17.

View in: PubMed
Litwin AH, Soloway IJ, Cockerham-Colas L, Reynoso S, Heo M, Tenore C, Roose RJ. Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program. Int J Drug Policy. 2015 Oct; 26(10):1014-9.

View in: PubMed
Qadir A. A Young Lady with Hypertension - Rare Presentation of a Common Disease. J Coll Physicians Surg Pak. 2015 Apr; 25 Suppl 1:S33-5.

View in: PubMed
Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Aliment Pharmacol Ther. 2015 Apr; 41(7):671-85.

View in: PubMed
Di Bisceglie AM, Sulkowski M, Gane E, Jacobson IM, Nelson D, DeSouza C, Alves K, George S, Kieffer T, Zhang EZ, Kauffman R, Asmal M, Koziel MJ. VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2014 Jul; 26(7):761-73.

View in: PubMed
Abraham GM, Spooner LM. Sofosbuvir in the treatment of chronic hepatitis C: new dog, new tricks. Clin Infect Dis. 2014 Aug 01; 59(3):411-5.

View in: PubMed
Gammal RS, Spooner LM, Abraham GM. Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection. Am J Health Syst Pharm. 2014 Feb 01; 71(3):204-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals